Antipsychotic Agents: all 1,814 studies that test it
Page 19 of 19. Open to participants first (97), then studies with results posted, then the rest; newest registration first within each.
- Infusion Laboratory: Protocol 5 (Flupenthixol) - 14Status unknownNCT00000349Phase 1
- Risperidone for Treatment of Cocaine Dependence in Outpatients - 12CompletedNCT00000347Phase 2
- Risperidone for the Treatment of Cocaine Dependence - 7CompletedNCT00000342Phase 2
- Infusion Laboratory: Protocol 3 (Risperidone) - 4Status unknownNCT00000339Phase 1
- Early Phase II Trials for Cocaine Medication Development - 1CompletedNCT00000317Phase 2
- Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2TerminatedNCT00000310Phase 2
- Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1TerminatedNCT00000309Phase 2
- Cocaine Abuse and ADHD - 10CompletedNCT00000275Phase 2
- Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9CompletedNCT00000274Phase 2
- Risperidone Treatment in Dually-Diagnosed Individuals - 2CompletedNCT00000267Phase 2
- Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1CompletedNCT00000266Phase 2
- Flupenthixol Decanoate in Methamphetamine Smoking - 1CompletedNCT00000241Phase 2
- Neurobiology of Opioid Dependence: 1 - 1WithdrawnNCT00000192Phase 2
- Ritanserin in Treatment of Cocaine Dependence - 1CompletedNCT00000187Phase 2